RxDoctor Payments Data

Christopher Arett, MD

Urology · Saint Louis, MONPI 1972600559

Payments from drug & device makers

$5,464in general payments, 2019–2025

Across 93 payments — averaging $58.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Teleflex LLC$693
  • Calyxo, Inc.$531
  • Janssen Scientific Affairs, LLC$361
  • Myriad Genetic Laboratories, Inc.$288
  • Procept Biorobotics Corporation$278
  • plus $1K from 14 others

What the payments were for

  • Speaking & faculty fees$2505%
  • Food & beverage$5,17995%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,464 in reported general payments places this provider in the 55th percentile of 250 urology providers in Missouri.

See all urology providers in Missouri

Medicare billing

Part B allowed, 2024
$174,660
Medicare patients
619
Services billed
6,793

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron136$81,798
GemtesaVibegron20$12,456
Tamsulosin Hcl650$7,889
Mirabegron ErMirabegron13$6,651
Oxybutynin Chloride ErOxybutynin Chloride180$3,824
Finasteride348$3,777
Silodosin33$2,466
Testosterone34$2,044
Testosterone Cypionate54$1,952
Methenamine Hippurate13$1,559
Tadalafil42$1,159
Dutasteride32$964
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst24$389
Solifenacin Succinate12$367
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim64$285

Paid to pharmacies, not to this prescriber.

Other urology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →